• 不 限
  • 期刊论文
  • 硕博论文
  • 会议论文
  • 报 纸
  • 英文论文
  2. 您的位置
  3. 首页
  4. 会议论文
  5. Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursor

Prophylactic vaccination against human papillomaviruses to prevent cervical cancer and its precursor

来源 :The 6th Biennial Conference of Asia Oceania Research Organis | 被引量 : 0次 | 上传用户：feiying7405
【摘 要】
：
The objectives of the protocol (Cochrane Database of Systematic Reviews 2013, Issue 12.Art.No.: CD009069.DOI: 10.1002/14651858.CD009069.pub2), are as follows:To evaluate the immunogenicity, clinical e
【作 者】
：
Arbyn M Bryant A Martin-Hirsch PPL Xu L Simoens C Markowitz L 
【机 构】
：
Unit of Cancer Epidemiology,Scientific Institute of Public Health,Brussels,Belgium
【出 处】
：
The 6th Biennial Conference of Asia Oceania Research Organis
【发表日期】
：
2014年2期
下载到本地 , 更方便阅读
下载此文 赞助VIP
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
The objectives of the protocol (Cochrane Database of Systematic Reviews 2013, Issue 12.Art.No.: CD009069.DOI: 10.1002/14651858.CD009069.pub2), are as follows:To evaluate the immunogenicity, clinical efficacy, and safety of prophylacticHPV vaccines in females.
其他文献
THE EXPERIENCE WITH CAREHPV(R) IN EL SALVADOR
El Salvador has one of the worlds highest cervical cancer incidence and mortality rates.To improve cervical cancer screening, the Ministry of Health (MOH), in cooperation with Basic Health Internation
会议
THE IMPLEMENTATION OF THE SCREENING TECHNOLOGIES IN DEVELOPING COUNTRIES
Although HPV vaccination will likely be the ultimate cervical cancer prevention strategy,given its effectiveness, the worldwide familiarity and acceptance of vaccination as a preventive strategy, and
会议
A prototype cervical cancer Test detecting E6/E7 oncoproteins of eight HPV types
Arbor Vita Corporation, in collaboration with PATH and CICAMS, developed the OncoE6TM Cervical Test ("E6 Test") for settings where ease of test use, short time from sample collection to result, and a
会议
Recent experiences in scaling up HPV vaccination and cervical screening in low-and middle-income cou
The knowledge that cervical neoplasia are caused by persistent infection with one of the high-risk types of human papilloma virus types and around 70％ cervical cancers are caused by HPV 16 or HPV 18 p
会议
Bangladesh experience on scaling up of visual inspection of cervix with acetic acid (VIA) screening
Objectives:To describe the experience on scaling up of VIA screening and to assess the diagnosis and management for pre-cancer at BSMMU.
会议
VIABangladeshCervical Cancer Screening
Opportunities and challenges in cervical cancer prevention in India
Cervical cancer rates are slowly declining in India and it is now the second most common cancer among women.
会议
ROLE OF ISSVD IN VIN DEFINITION
Preinvasive neoplasia of the vulva has been recognized for over 90 years, but terminology to describe this disease has been confusing.
会议
Safety, pharmacokinetics and efficacy phase ii-a study of AP611074,a HPV-specific treatment for cond
Objectives: AP611074 is a new drug that inhibits the interaction of E1/E2 proteins of HPV6/11, blocking HPV replication.We aimed to obtain proof-of-concept of AP611074 in the topical treatment of cond
会议
HPVantiviral drugcondylomaano-genital warts
Does the HPV-16/18 AS04-adjuvanted vaccine benefit women with cervical disease and dose it have effi
Objectives:We investigated whether women who underwent subsequent cervical excision during the PATRICIA trial (AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine) benefited from reduced incidenc
会议
THE ROLE OF CERVISTA HR HPV TEST IN CERVICAL CANCER SCREENING, A CROSS-SECTIONAL STUDY OF CLINICAL A
Background: The type distribution of high-risk (HR) HPV types associated with cervical neoplasia is somewhat different in China compared to that of Europe or North America, with the most prevalent typ
会议